Rafferty Asset Management
TBIO

Rafferty Asset Management’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Rafferty Asset Management’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-121,947
Closed -$3.36M – 1327
2021
Q2 		$3.36M Sell
121,947
-13,481
-10% -$265K 0.02% 475
2021
Q1 		$2.23M Buy
135,428
+109,747
+427% +$2.5M 0.02% 591
2020
Q4 		$473K Sell
25,681
-127,062
-83% -$2.27M ﹤0.01% 696
2020
Q3 		$2.08M Buy
152,743
+136,710
+853% +$2.11M 0.03% 404
2020
Q2 		$287K Buy
+16,033
New +$242K ﹤0.01% 840

Rafferty Asset Management's TBIO Position: Q3 2021 in Review

Rafferty Asset Management sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 121,947 shares — an estimated $3.36M sold.

Rafferty Asset Management first reported a position in TBIO in Q2 2020 and held it in 5 quarters. The position peaked at $3.36M in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

  • Rafferty Asset Management reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Rafferty Asset Management sold 121,947 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $3.36M.
  • Rafferty Asset Management first reported a position in Translate Bio, Inc. Common Stock in Q2 2020 and held it in 5 quarters.
  • Rafferty Asset Management's Translate Bio, Inc. Common Stock position peaked at $3.36M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Rafferty Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.